- Home
- NCNA vs CELZ Comparison
NCNA vs CELZ Comparison
Compare NCNA & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- CELZ
- Stock Information
- Founded
- NCNA 1997
- CELZ 1998
- Country
- NCNA United Kingdom
- CELZ United States
- Employees
- NCNA N/A
- CELZ N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- NCNA Health Care
- CELZ Health Care
- Exchange
- NCNA Nasdaq
- CELZ Nasdaq
- Market Cap
- NCNA 4.4M
- CELZ 4.7M
- IPO Year
- NCNA 2017
- CELZ N/A
- Fundamental
- Price
- NCNA $1.49
- CELZ $2.70
- Analyst Decision
- NCNA Buy
- CELZ
- Analyst Count
- NCNA 2
- CELZ 0
- Target Price
- NCNA $25.00
- CELZ N/A
- AVG Volume (30 Days)
- NCNA 138.4K
- CELZ 70.6K
- Earning Date
- NCNA 11-26-2024
- CELZ 11-08-2024
- Dividend Yield
- NCNA N/A
- CELZ N/A
- EPS Growth
- NCNA N/A
- CELZ N/A
- EPS
- NCNA N/A
- CELZ N/A
- Revenue
- NCNA N/A
- CELZ $11,000.00
- Revenue This Year
- NCNA N/A
- CELZ N/A
- Revenue Next Year
- NCNA N/A
- CELZ N/A
- P/E Ratio
- NCNA N/A
- CELZ N/A
- Revenue Growth
- NCNA N/A
- CELZ N/A
- 52 Week Low
- NCNA $1.49
- CELZ $2.52
- 52 Week High
- NCNA $19.40
- CELZ $10.28
- Technical
- Relative Strength Index (RSI)
- NCNA 34.09
- CELZ 37.79
- Support Level
- NCNA $1.53
- CELZ $2.52
- Resistance Level
- NCNA $1.66
- CELZ $2.96
- Average True Range (ATR)
- NCNA 0.09
- CELZ 0.39
- MACD
- NCNA 0.05
- CELZ -0.12
- Stochastic Oscillator
- NCNA -3.70
- CELZ 7.89
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.